二甲双胍用于衰老和癌症预防。
Metformin for aging and cancer prevention.
作者信息
Anisimov Vladimir N
机构信息
Department of Carcinogenesis and Oncogerontology, N.N. Petrov Research Institute of Oncology, St. Petersburg 197758, Russia.
出版信息
Aging (Albany NY). 2010 Nov;2(11):760-74. doi: 10.18632/aging.100230.
Abstract
Studies in mammals have led to the suggestion that hyperglycemia and hyperinsulinemia are important factors in aging. Insulin/insulin-like growth factor 1 (IGF-1) signaling molecules that have been linked to longevity include daf-2 and InR and their homologues in mammals, and inactivation of the corresponding genes increases life span in nematodes, fruit flies and mice. It is possible that the life-prolonging effect of caloric restriction is due to decreasing IGF-1 levels. Evidence has emerged that antidiabetic drugs are promising candidates for both life span extension and prevention of cancer. Thus, antidiabetic drugs postpone spontaneous carcinogenesis in mice and rats, as well as chemical and radiation carcinogenesis in mice, rats and hamsters. Furthermore metformin seems to decrease cancer risk in diabetic patients.
摘要
对哺乳动物的研究表明，高血糖和高胰岛素血症是衰老的重要因素。与长寿相关的胰岛素/胰岛素样生长因子1（IGF-1）信号分子包括秀丽隐杆线虫中的daf-2和果蝇中的InR及其在哺乳动物中的同源物，相应基因的失活可延长线虫、果蝇和小鼠的寿命。热量限制的延寿作用可能是由于IGF-1水平降低。有证据表明，抗糖尿病药物有望用于延长寿命和预防癌症。因此，抗糖尿病药物可延缓小鼠和大鼠的自发癌变，以及小鼠、大鼠和仓鼠的化学和辐射致癌。此外，二甲双胍似乎可降低糖尿病患者的癌症风险。
相似文献
1
Metformin for aging and cancer prevention.二甲双胍用于衰老和癌症预防。
Aging (Albany NY). 2010 Nov;2(11):760-74. doi: 10.18632/aging.100230.
2
The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.生长激素-胰岛素-IGF-1 信号通路在衰老和癌症中的关键作用。
Crit Rev Oncol Hematol. 2013 Sep;87(3):201-23. doi: 10.1016/j.critrevonc.2013.01.005. Epub 2013 Feb 21.
3
Metformin: do we finally have an anti-aging drug?二甲双胍：我们终于有抗衰老药物了吗？
Cell Cycle. 2013 Nov 15;12(22):3483-9. doi: 10.4161/cc.26928. Epub 2013 Oct 24.
4
Central and peripheral effects of insulin/IGF-1 signaling in aging and cancer: antidiabetic drugs as geroprotectors and anticarcinogens.胰岛素/胰岛素样生长因子-1信号通路在衰老和癌症中的中枢及外周效应：抗糖尿病药物作为老年保护剂和抗癌剂
Ann N Y Acad Sci. 2005 Dec;1057:220-34. doi: 10.1196/annals.1356.017.
5
Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention.胰岛素/胰岛素样生长因子-1信号通路驱动衰老和癌症，作为药物干预的靶点。
Exp Gerontol. 2003 Oct;38(10):1041-9. doi: 10.1016/s0531-5565(03)00169-4.
6
[Role of the growth hormone-insulin-like growth factor-1-insulin system signaling in aging and longevity: evolutional aspect].生长激素 - 胰岛素样生长因子 -1 - 胰岛素系统信号传导在衰老和长寿中的作用：进化方面
Ross Fiziol Zh Im I M Sechenova. 2008 Sep;94(9):1092-109.
7
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.二甲双胍对HER-2/neu转基因小鼠寿命及自发性乳腺肿瘤发生的影响。
Exp Gerontol. 2005 Aug-Sep;40(8-9):685-93. doi: 10.1016/j.exger.2005.07.007.
8
Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice.二甲双胍对129/Sv小鼠衰老、寿命和自发肿瘤发生影响的性别差异。
Aging (Albany NY). 2010 Dec;2(12):945-58. doi: 10.18632/aging.100245.
9
Metformin slows down aging and extends life span of female SHR mice.二甲双胍可延缓雌性自发性高血压大鼠（SHR）衰老并延长其寿命。
Cell Cycle. 2008 Sep 1;7(17):2769-73. doi: 10.4161/cc.7.17.6625. Epub 2008 Sep 11.
10
If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice.如果在生命早期开始，二甲双胍治疗可延长雌性SHR小鼠的寿命并延缓肿瘤发生。
Aging (Albany NY). 2011 Feb;3(2):148-57. doi: 10.18632/aging.100273.
引用本文的文献
1
The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies.衰老、昼夜节律和癌症的共同特征及相互关联途径：对治疗策略的启示
Research (Wash D C). 2025 Mar 5;8:0612. doi: 10.34133/research.0612. eCollection 2025.
2
The combined treatment with ketogenic diet and metformin slows tumor growth in two mouse models of triple negative breast cancer.生酮饮食与二甲双胍联合治疗可减缓三阴性乳腺癌两种小鼠模型中的肿瘤生长。
Transl Med Commun. 2024;9(1). doi: 10.1186/s41231-024-00178-8. Epub 2024 Jun 22.
3
The combination of metformin and high glucose increased longevity of a DAF-16/FOXO-independent manner: cancer/diabetic model via .二甲双胍和高葡萄糖的联合作用以 DAF-16/FOXO 非依赖性方式延长寿命：通过. 的癌症/糖尿病模型
Front Endocrinol (Lausanne). 2024 Nov 4;15:1435098. doi: 10.3389/fendo.2024.1435098. eCollection 2024.
4
The Combined Treatment with Ketogenic Diet and Metformin Slows Tumor Growth in Two Mouse Models of Triple Negative Breast Cancer.生酮饮食与二甲双胍联合治疗可减缓三阴性乳腺癌两种小鼠模型中的肿瘤生长。
Res Sq. 2023 Dec 20:rs.3.rs-3664129. doi: 10.21203/rs.3.rs-3664129/v1.
5
Lipid and glucose metabolism in senescence.衰老过程中的脂质和葡萄糖代谢。
Front Nutr. 2023 Aug 23;10:1157352. doi: 10.3389/fnut.2023.1157352. eCollection 2023.
6
Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes.二甲双胍：超越糖尿病的潜在机制和治疗效用的综述。
Drug Des Devel Ther. 2023 Jun 26;17:1907-1932. doi: 10.2147/DDDT.S409373. eCollection 2023.
7
Therapeutic Antiaging Strategies.治疗性抗衰老策略
Biomedicines. 2022 Oct 8;10(10):2515. doi: 10.3390/biomedicines10102515.
8
Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?促进大脑健康衰老的最新神经治疗策略：我们做到了吗？
Aging Dis. 2022 Feb 1;13(1):175-214. doi: 10.14336/AD.2021.0705. eCollection 2022 Feb.
9
A Comparative Study of the Lipophilicity of Metformin and Phenformin.二甲双胍和苯乙双胍脂溶性的比较研究。
Molecules. 2021 Oct 31;26(21):6613. doi: 10.3390/molecules26216613.
10
Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products.糖尿病与癌症：代谢关联、治疗挑战及天然产物的作用
Molecules. 2021 Apr 10;26(8):2179. doi: 10.3390/molecules26082179.
本文引用的文献
1
[Effect of metformin on the magnitude of oxidative stress in patients with type 2 diabetes mellitus].二甲双胍对2型糖尿病患者氧化应激程度的影响
Probl Endokrinol (Mosk). 2007 Feb 15;53(1):3-7. doi: 10.14341/probl20075313-7.
2
[Melatonin and metformin inhibit skin carcinogenesis induced by benz(a)pyrene in mice].褪黑素和二甲双胍抑制苯并(a)芘诱导的小鼠皮肤癌发生
Vopr Onkol. 2010;56(5):583-7.
3
Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging.白藜芦醇、雷帕霉素和二甲双胍延长寿命：饮食限制模拟物促进健康衰老的前景。
Biofactors. 2010 Sep-Oct;36(5):377-82. doi: 10.1002/biof.127.
4
Metformin prevents tobacco carcinogen--induced lung tumorigenesis.二甲双胍可预防烟草致癌物诱导的肺癌发生。
Cancer Prev Res (Phila). 2010 Sep;3(9):1066-76. doi: 10.1158/1940-6207.CAPR-10-0055. Epub 2010 Sep 1.
5
Metformin and other biguanides in oncology: advancing the research agenda.二甲双胍和其他双胍类药物在肿瘤学中的应用：推进研究议程。
Cancer Prev Res (Phila). 2010 Sep;3(9):1060-5. doi: 10.1158/1940-6207.CAPR-10-0175. Epub 2010 Sep 1.
6
Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond.现代癌症患者代谢康复方法：双胍类药物（苯乙双胍和二甲双胍）及其他。
Future Oncol. 2010 Aug;6(8):1313-23. doi: 10.2217/fon.10.87.
7
Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells.二甲双胍与乳腺癌中的能量代谢：从胰岛素生理学到肿瘤起始干细胞。
Curr Mol Med. 2010 Oct;10(7):674-91. doi: 10.2174/156652410792630625.
8
Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.二甲双胍通过激活 AMP 激活的蛋白激酶抑制氧化偶氮甲烷诱导的结直肠隐窝异常。
Mol Carcinog. 2010 Jul;49(7):662-71. doi: 10.1002/mc.20637.
9
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.肥胖、高胰岛素血症与乳腺癌：二甲双胍的新靶点和新作用。
Expert Rev Mol Diagn. 2010 May;10(4):509-19. doi: 10.1586/erm.10.22.
10
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.二甲双胍不依赖于 AMPK，以 rag GTPase 依赖性方式抑制 mTORC1。
Cell Metab. 2010 May 5;11(5):390-401. doi: 10.1016/j.cmet.2010.03.014.
Zotero 插件